This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.

This study has been completed.
Information provided by:
Nantes University Hospital Identifier:
First received: September 12, 2005
Last updated: June 30, 2008
Last verified: June 2008
Randomized, prospective, multicenter study in order to assess the usefulness of antimicrobial prophylaxis in children with isolated vesico-ureteral reflux (grade III or less).

Condition Intervention
Urinary Tract Infection Procedure: Antimicrobial prophylaxis

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance.

Resource links provided by NLM:

Further study details as provided by Nantes University Hospital:

Primary Outcome Measures:
  • End point : recurrence of urinary tract infection during the study period (0 è 18 months)

Secondary Outcome Measures:
  • 1) Type of urinary tract infection (pyelonephritis or cystitis)
  • 2) Evaluation of the quality of life with a validated questionnaire done at 9 months

Estimated Enrollment: 232
Study Start Date: April 2001
Study Completion Date: July 2006
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:
A voiding cystourethrogram was performed for each child less than 3 years old with a first urinary tract infection. In case of vesico-ureteral reflux, a randomization was done between continuous antimicrobial prophylaxis with low dose of trimethoprim-sulfamethoxazole and no antibioprophylaxis. Duration of follow up was 18 months.

Ages Eligible for Study:   up to 3 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children less than 3 years old
  • First proved urinary tract infectionIsolated vesico-ureteral reflux
  • Parents have been fully informed and have given written informed consent to participate in the study

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00200616

Nantes University Hospital
Nantes, France
Sponsors and Collaborators
Nantes University Hospital
Principal Investigator: Claude GUYOT, MD Nantes University Hospital
  More Information

Responsible Party: Claude GUYOT, Nantes University Hospital Identifier: NCT00200616     History of Changes
Other Study ID Numbers: BRD/00/10-O
Study First Received: September 12, 2005
Last Updated: June 30, 2008

Keywords provided by Nantes University Hospital:
Urinary tract infection
Vesico-renal reflux
Antimicrobial prophylaxis
Recurrence of urinary tract infection

Additional relevant MeSH terms:
Urinary Tract Infections
Vesico-Ureteral Reflux
Urologic Diseases
Urinary Bladder Diseases
Anti-Infective Agents
Trimethoprim, Sulfamethoxazole Drug Combination
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Renal Agents
Antiprotozoal Agents
Antiparasitic Agents processed this record on August 23, 2017